Top Markets
Coin of the day
Vascular Biogenics Ltd. Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

VBLT
Clasificación en acciones #33542
Vascular Biogenics Ltd. (VBLT) operates as a clinical-stage biopharmaceutical... Vascular Biogenics Ltd. (VBLT) operates as a clinical-stage biopharmaceutical company, dedicated to developing therapeutic solutions for cancer and immune-inflammatory diseases. The company's activities are concentrated in Israel and the United States. Its pipeline is anchored by two core technological platforms: First, a gene-based vascular targeting system that focuses on newly formed blood vessels; and second, an antibody-based monocyte targeting technology that aims to specifically inhibit monocyte migration, particularly for immune-inflammatory applications. VBLT's flagship product candidate, VB-111, a gene-based biologic, is undergoing several clinical trials. It has reached Phase III for the treatment of recurrent, platinum-resistant ovarian cancer. Additionally, it is in Phase II trials for recurrent glioblastoma and colorectal cancer. Moreover, VB-111 has completed Phase II clinical trials for thyroid cancer. The company is also developing VB-601 for a variety of inflammatory indications and VB-611 for different types of solid tumors. Initially incorporated as Medicard Ltd. in 2000, the company rebranded as Vascular Biogenics Ltd. in January 2003. Its main offices are situated in Modi'in, Israel.
Precio por acción
$0.155
Última sincronización: 2023-10-16
Capitalización bursátil
$7.44M
Cambio (1 día)
-9.36%
Cambio (1 año)
0.00%
País
IL
Comercio Vascular Biogenics Ltd. (VBLT)

Categoría

Historial del precio de la acción de Vascular Biogenics Ltd. (VBLT)
Precio más alto de cierre: $0.23 el 2023-10-01

Precio más bajo de cierre: $10.25 el 2014-07-01
Historial del precio de la acción de Vascular Biogenics Ltd. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 82.09%
2022 -94.03%
2021 21.62%
2020 45.39%
2019 14.22%
2018 -84.70%
2017 40.20%
2016 -5.03%
2015 -14.31%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE